Dalbavancin as long-term suppressive therapy for patients with Gram-positive bacteremia due to an intravascular source – a series of four cases - University of Regensburg Publication Server

URN to cite this document:: urn:nbn:de:bvb:355-epub-447490
DOI to cite this document:: 10.5283/epub.44749

Hitzenbichler, Florian

; Mohr, Arno ; Camboni, Daniele ; Simon, Michaela ; Salzberger, Bernd ; Hanses, Frank

Preview

License: Creative Commons Attribution 4.0
PDF - Published Version
(538kB)

Date of publication of this fulltext: 04 Feb 2021 14:19

Alternative links to fulltext:DOI Publisher

This publication is part of the DEAL contract with Springer.

Details

Preview

Indexed in

Export bibliographical data

Abstract

We present four cases with Gram-positive bacteremia (pathogens: MRSAn = 1, Enterococcusspp.n = 3) due to an intravascular source (left ventricular assist device:n = 2, transfemoral aortic valve implantationn = 1, prosthetic aortic valve:n = 1) where no curative treatment was available. These patients received indefinite, chronic suppressive (palliative) therapy with dalbavancin (500 mg weekly or ...